I.V. containers have not experienced significant change since the introduction of plastic to replace glass in the 70s. This I.V. bag offers a variety of features that address many concerns healthcare providers have with today’s more traditional options. Hospira Inc.
Silicone has emerged as one of the most researched biomaterials available to pharmaceutical makers and medical device manufacturers. As such, it readily lends itself to being an ideal choice for use in combination products where these two industries merge.
Combination products can cause twice as many problems for companies in the testing of these devices since they require expertise in two highly regulated specialtiesmedical devices and pharmaceuticals. This article offers a number of areas manufacturers of these devices will have to consider.
These 0.079 in. and 0.1 in. board-to-board connectors are 100% RoHS-compliant. Male and female headers are offered in single, double, and quad row configurations, and in both plated through-hole (PTH) and surface mount (SMT) versions.
The LNB Series is a product family of high density, ultra low noise, fully isolated DC/DC converters. The series offers output ripple of 10 mVp-p and operate over input voltage ranges of 4.
The Flextrak Plasma Processing System improves the reliability and quality of medical devices through surface modification and ultra-cleaning. The plasma processes improve the bond uniformity and adhesion between dissimilar materials, enhancing the performance of end products, such as stents.
A patent-pending, advanced UV polymer optical bonding solution that improves contrast, enables brighter graphics, enhances ruggedness, and offers a more robust overall visual experience for a virtually limitless variety of LCD solutions is available.
Medical monitoring devices are moving out of the hospital and into the hands of consumers, driving a shift to a platform approach for designing medical electronics.
Reed Life Sciences is excited to announce PharmaMedDevicethe only comprehensive forum that fully illuminates the convergence of the medical device, pharmaceutical, and biologic industries. The inaugural event will be co-located with Interphex, April 24-26, 2007, at the Jacob K.
As the development and use of combination products increases, the FDA realizes it needs to establish specific guidelines to oversee this technology. This article explores some of the pivotal issues pertaining to how a combination drug-device, drug-biologic, or device-biologic is regulated.
Creating a contaminant and/or vacuum-free drug delivery device, such as an inhaler, nasal pump, or eye dropper, is a difficult task. This article examines a venting option that enables a closed, equalized system for multiunit-dose drug packaging.
Companies need to move rapidly to take advantage of developing trends in healthcare treatment modalities. This article examines many of the factors combination product manufacturers need to consider to accelerate their product’s time to market.
This article describes how a design-centered company leveraged its innovative consumer design expertise from the audio-visual world and transferred this knowledge to its drug delivery device affiliate, while receiving the collaborative assistance from a computer technology leader.
Dissolvable films are currently used in a variety of applications such as consumer breath freshener products and as vehicles for over-the-counter drug delivery. Manufacturers are also exploring the technology’s unique characteristics for use with in vitro diagnostic devices.
Since most manufacturers do not staff experts in every area of technology they may need to create a finished medical device, collaborating with professionals who are can be the ideal formula for success.